Results 11 to 20 of about 1,090,016 (327)

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.

The Journal of the National Comprehensive Cancer Network, 2023
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive
A. Benson, M. D'Angelica, T. Abrams, D. Abbott, Aijaz Ahmed, D. Anaya, R. Anders, C. Are, Melinda Bachini, David Binder, M. Borad, C. Bowlus, Daniel B. Brown, Adam M. Burgoyne, Jason A. Castellanos, P. Chahal, J. Cloyd, A. Covey, E. Glazer, W. Hawkins, R. Iyer, R. Jacob, Lawrence Jennings, R. Kelley, R. Kim, Matthew Levine, M. Palta, James Park, Steven Raman, S. Reddy, Sean Ronnekleiv-Kelly, V. Sahai, Gagandeep Singh, S. Stein, A. Turk, J. Vauthey, A. Venook, A. Yopp, Nicole R Mcmillian, Ryan Schonfeld, Cindy Hochstetler   +40 more
semanticscholar   +1 more source

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Liver international (Print), 2023
The TOPAZ‐1 phase III trial reported a survival benefit with the anti‐programmed death cell ligand 1 (anti‐PD‐L1) durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer.
M. Rimini, L. Fornaro, S. Lonardi, M. Niger, D. Lavacchi, T. Pressiani, J. Lucchetti, G. Giordano, A. Pretta, E. Tamburini, C. Pirrone, I. Rapposelli, A. Diana, E. Martinelli, I. Garajová, Francesca Simionato, M. Schirripa, V. Formica, C. Vivaldi, E. Caliman, M. Rizzato, Valentina Zanuso, F. Nichetti, L. Angotti, M. Landriscina, M. Scartozzi, M. Ramundo, A. Pastorino, B. Daniele, Noemi Cornara, M. Persano, Eleonora Gusmaroli, Riccardo Cerantola, F. Salani, F. Ratti, L. Aldrighetti, S. Cascinu, L. Rimassa, L. Antonuzzo, A. Casadei‐Gardini   +39 more
semanticscholar   +1 more source

The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: A review

Annals of Hepato-Biliary-Pancreatic Surgery, 2023
Helicobacter pylori is a gram-negative pathogen commonly associated with peptic ulcer disease and gastric cancer. H. pylori infection has also been reported in cholelithiasis, cholecystitis, gallbladder polyps, and biliary tract cancers.
Klay Puay Khim Lim, Aaron Jia Loong Lee, Xiuting Jiang, T. Teng, V. Shelat   +4 more
semanticscholar   +1 more source

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)

Journal of hepato-biliary-pancreatic sciences, 2022
Gemcitabine/cisplatin (GC) combination therapy has been the standard palliative chemotherapy for patients with advanced biliary tract cancer (BTC). No randomized clinical trials have been able to demonstrate the survival benefit over GC during the past ...
T. Ioka, M. Kanai, Shogo Kobayashi, D. Sakai, H. Eguchi, Hideo Baba, S. Seo, A. Taketomi, T. Takayama, H. Yamaue, Masahiro Takahashi, M. Sho, K. Kamei, J. Fujimoto, M. Toyoda, J. Shimizu, T. Goto, Y. Shindo, K. Yoshimura, E. Hatano, Hiroaki Nagano   +20 more
semanticscholar   +1 more source

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

Cancers, 2021
Simple Summary Over the last decade, immune checkpoint inhibitors (ICIs) targeting programmed death 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) have dramatically changed the therapeutic algorithm of several ...
A. Rizzo, A. Ricci, G. Brandi
semanticscholar   +1 more source

Pathologies of Precursor Lesions of Biliary Tract Carcinoma

Cancers, 2022
Simple Summary Carcinomas and precursor lesions of the biliary tract belong to a spectrum of pancreatobiliary neoplasms that share common histology and cell lineages.
Y. Nakanuma, Yuko Kakuda, T. Sugino, Yasunori Sato, Y. Fukumura   +4 more
semanticscholar   +1 more source

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.

JAMA Oncology, 2020
Importance Currently, there is no established second-line systemic treatment for biliary tract cancer (BTC). Preclinical data have demonstrated that the presence of tumor-infiltrating CD8 T cells and programmed cell death 1 ligand 1-expressing tumor ...
R. Kim, V. Chung, O. Alese, B. El-Rayes, Daneng Li, T. Al-Toubah, M. Schell, Jun-min Zhou, A. Mahipal, B. Kim, Dae Won Kim   +10 more
semanticscholar   +1 more source

The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017

Cancer, 2021
The global burden of gallbladder and biliary tract cancer (GBTC) is increasing. A comprehensive evaluation of the burden is crucial to improve strategies for GBTC prevention and treatment.
Guoqing Ouyang, Qiang Liu, Yongrong Wu, Zhen Liu, Wuchang Lu, Shuai Li, Guangdong Pan, Xiang Chen   +7 more
semanticscholar   +1 more source

Epidemiology, risk factors, diagnosis, and treatment of intra-abdominal traumatic neuromas - a narrative review

BMC Gastroenterology, 2023
Highlights This is the largest case series and case review of traumatic neuroma in the abdominal cavity. We conclude and update the clinical and epidemiological characteristics of TN in the abdominal cavity. We assessed and discussed the management of TN
Yaoqun Wang, Sishu Yang, Bei Li, Cunyong Shuai, Xianze Xiong, Jiong Lu   +5 more
doaj   +1 more source

Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis

Frontiers in Oncology, 2023
ObjectiveThe aim of the study was to evaluate the similarities and differences between gallbladder adenosquamous carcinoma (GBASC) and pure gallbladder adenocarcinoma (GBAC).MethodsPatients with GBASC and GBAC from 2010 to 2020 were analyzed in terms of ...
Tian-Run Lv, Fei Liu, Zuo-Yu Liang, Rui-Qi Zou, Wen-Jie Ma, Hai-Jie Hu, Fu-Yu Li   +6 more
doaj   +1 more source